Home › Multiple Sclerosis › Washington › Seattle
Multiple Sclerosis clinical trials in Seattle, WA
6 studies for Multiple Sclerosis are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
RecruitingPhase 1/2
- Providence Swedish, Seattle
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- Seattle Neuropsychiatric Treatment Center, Seattle
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
RecruitingPhase 1
- Research Site, Seattle
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness Practice
Recruiting
- University of Washington, Seattle
Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue
Recruiting
- Multiple Sclerosis Center at UW Medical Center - Northwest, Seattle
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Birmingham, AL8 studies
- San Francisco, CA8 studies
- Columbus, OH7 studies
- Aurora, CO7 studies
- Baltimore, MD7 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Myelodysplastic Syndromes21 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.